Cover image of the article: European vs. Egyptian HCV-4 Patients with Elevated Baseline HCV RNA, Treated with PEG-IFN-α2a and Ribavirin: The Role of Rapid and Early Virologic Response

Image Credit:Hepat Mon

European vs. Egyptian HCV-4 Patients with Elevated Baseline HCV RNA, Treated with PEG-IFN-α2a and Ribavirin: The Role of Rapid and Early Virologic Response

Authors

Dimitrios Dimitroulopoulos1,*, Ioannis Elefsiniotis2, Christos Pavlidis3, Dimitrios Xinopoulos1, Klisthenis Tsamakidis1, Stamatina Patsavela1, Dimitrios Kypreos1, Ageliki Ferderigou4, Dimitrios Korkolis5, Sotirios Koutsounas6, Georgios Saroglou7, Emmanouil Paraskevas8
How to Cite:Dimitroulopoulos D, Elefsiniotis I, Pavlidis C, Xinopoulos D, Tsamakidis K, et al. European vs. Egyptian HCV-4 Patients with Elevated Baseline HCV RNA, Treated with PEG-IFN-α2a and Ribavirin: The Role of Rapid and Early Virologic Response. Hepat Mon. 2010;10(3):e92981. doi:

References

  • 1.
    The references are available in the PDF file.

Copyright

© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

1
Jan
2015
Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1

Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1

Heidar Sharafi,
Seyed Moayed Alavian,
Maryam Keshvari

Sharafi H, Alavian SM, Keshvari M. Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1. Hepat Mon. 2015;15(1):e24955. doi: https://doi.org/10.5812/hepatmon.24955

31
Dec
2008
Optimizing Treatment with Pegylated Interferon-Ribavirin of Genotype 3 Chronic Hepatitis C: More Questions than Answers

Optimizing Treatment with Pegylated Interferon-Ribavirin of Genotype 3 Chronic Hepatitis C: More Questions than Answers

Alessio Aghemo,
Roberta D'Ambrosio,
Maria Grazia Rumi,
Massimo Colombo

Aghemo A, D'Ambrosio R, Rumi M, Colombo M. Optimizing Treatment with Pegylated Interferon-Ribavirin of Genotype 3 Chronic Hepatitis C: More Questions than Answers. Hepat Mon. 2008;8(4):. doi:

14
Dec
2013
Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin

Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin

Zaigham Abbas,
Ghiasun Nabi Tayyab,
Mustafa Qureshi,
Mohammad Sadik Memon,
Amna Subhan,
Tanzila Shakir
,et al.

Abbas Z, Tayyab GN, Qureshi M, Memon MS, Subhan A, et al. Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin. Hepat Mon. 2013;13(12):e14146. doi: https://doi.org/10.5812/hepatmon.14146

27
May
2013
The Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian Study

The Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian Study

Maissa El Raziky,
Waleed Fouad Fathalah,
Wafaa Ahmed El-akel,
Ahmed Salama,
Gamal Esmat,
Mahassen Mabrouk
,et al.

El Raziky M, Fathalah WF, El-akel WA, Salama A, Esmat G, et al. The Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian Study. Hepat Mon. 2013;13(5):10069. doi: https://doi.org/10.5812/hepatmon.10069

23
Jun
2015
Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study

Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study

Alessandro Federico,
Mario Masarone,
Marco Romano,
Marcello Dallio,
Valerio Rosato,
Marcello Persico

Federico A, Masarone M, Romano M, Dallio M, Rosato V, et al. Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study. Hepat Mon. 2015;15(6):e18640. doi: https://doi.org/10.5812/hepatmon.15(6)2015.18640

More by these authors

Dimitrios DimitroulopoulosPubMedScholar
Ioannis ElefsiniotisPubMedScholar
Christos PavlidisPubMedScholar
Dimitrios XinopoulosPubMedScholar
Klisthenis TsamakidisPubMedScholar
Stamatina PatsavelaPubMedScholar
Dimitrios KypreosPubMedScholar
Ageliki FerderigouPubMedScholar
Dimitrios KorkolisPubMedScholar
Sotirios KoutsounasPubMedScholar
Georgios SaroglouPubMedScholar
Emmanouil ParaskevasPubMedScholar
Share
Cited by
Metrics
Indexed in